Product Information

AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.2662 per EA under NDC 27241008503. Its NADAC has been published 509 times since Feb 22, 2017.

FDA first approved this application on Oct 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 10-20 MG

Amlodipine besylate and Olmesartan medoxomil
$0.2662per EA

Strength

10; 20 mg/1; mg/1

NDC

27241008503

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207216

FDA Approved

10/28/2016

TE Code

AB

On Market Since

2/6/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 509 times since Feb 22, 2017, and over the history we have for it it has declined 72.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2662 per EA
All-time high$0.9788 (Oct 11, 2017)
All-time low$0.2298 (Aug 19, 2026)
52-week high$0.3303
52-week low$0.2298
Median price$0.4377
Average price$0.5281
Largest weekly change+68.6% (Nov 22, 2023)
Weeks tracked509
Tracking sinceFeb 22, 2017

Price History

1W

-2.1%

1M

+7.5%

3M

+15.8%

6M

-9.9%

1Y

-10.0%

3Y

-11.1%

5Y

-4.9%

All

-72.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Ajanta Pharma USA Inc., is $0.2662 per EA (NDC 27241008503), effective Nov 18, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 72.5%. It has been tracked across 509 weekly CMS publications since Feb 22, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?

Since Feb 22, 2017, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2298 (Aug 19, 2026) to a high of $0.9788 (Oct 11, 2017), with a median of $0.4377 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-20 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?

AMLODIPINE-OLMESARTAN 10-20 MG (NDC 27241008503) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.